HIV-1-infection Clinical Trials in Atlanta, Georgia

4 studies are recruiting for hiv-1-infection in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

   The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)), in virologically suppressed peopl…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Emory University Hospital Midtown Infectious Disease Clinic, Atlanta, Georgia

   Locations

   55 in total

   Run by

   Gilead Sciences

   See if you can join NCT07645287 on ClinicalTrials.gov

2. Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

   The purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a long-acting injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

   Stage

   Phase 1

   Ages

   2 to 11

   Site

   Site 5030, Emory University School of Medicine NICHD CRS, Atlanta, Georgia

   Locations

   12 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT05660980 on ClinicalTrials.gov

3. Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

   The goal of this clinical study is to learn more about the study drug, lenacapavir (LEN). The study will assess the safety, tolerability, and efficacy of long-acting LEN when combined with other medicines in adolescents and children living with HIV-1 who weigh at least 35 kg and have been treated b…

   Stage

   Phase 2

   Ages

   Up to 17

   Site

   Grady Health System, Ponce De Leon Center, Atlanta, Georgia

   Locations

   9 in total

   Run by

   Gilead Sciences

   See if you can join NCT06749054 on ClinicalTrials.gov

4. Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

   IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and thei…

   Stage

   Not phased

   Ages

   Any age

   Site

   5030, Emory University School of Medicine Clinical Research Site, Atlanta, Georgia

   Locations

   11 in total

   Run by

   International Maternal Pediatric Adolescent AIDS Clinical Trials Group

   See if you can join NCT07293559 on ClinicalTrials.gov